Use of network meta-analysis in clinical guidelines

Bulletin of the World Health Organization

Volumn 94, Issue 10, 2016, Pages 782-784

  Kanters, Steve ^a   Ford, Nathan ^b   Druyts, Eric ^c   Thorlund, Kristian ^c   Mills, Edward J ^c   Bansback, Nick ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Department of Health Analytics   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION MAKING; DISEASE TREATMENT; DRUG; EPIDEMIOLOGY; HUMAN IMMUNODEFICIENCY VIRUS; META-ANALYSIS; NETWORK ANALYSIS; PERCEPTION; PUBLIC HEALTH; SOCIAL POLICY; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ARTICLE; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; PRACTICE GUIDELINE; PUBLIC HEALTH; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

IRELAND; UNITED KINGDOM;

EID: 84989336931     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.16.174326     Document Type: Article

References (14)

1. Consolidated guidelines on HIV prevention, diagnosis, treatment 4. and care for key populations. 2016 update. Geneva: World Health Organization; 2016. Available from: http://apps.who.int/iris/bitstre am/10665/246200/1/9789241511124-eng.pdf [cited 2016 Jul 29].
2. Guidelines for the screening, care and treatment of persons with chronic hepatitis Cinfection. Updated version, April 2016. Geneva: World. Health Organization; 2016. Available from: http://apps.who.int/iris/bitstream/10665/205035/1/9789241549615_eng.pdf [cited 2016 Jul 29].
3. Nasser SM, Cooke G, Kranzer K, Norris SL, Olliaro P, Ford N. Strength of recommendations in WHO guidelines using GRADE was associated with 7. uptake in national policy. J Clin Epidemiol. 2015 Jun;68(6):703-7. doi: http://dx.doi.org/10.1016/j.jclinepi.2014.11.006 PMID: 25578218
4. Oxman AD, Lavis JN, Fretheim A. Use of evidence in WHO recommendations. Lancet. 2007 Jun 2;369(9576):1883-9. doi:http://dx.doi.org/10.1016/S0140-6736(07)60675-8 PMID: 17493676
5. WHO handbook for guideline development. 2nd ed. Geneva: World Health Organization; 2014.
6. Hallett TB, Menzies NA, Revill P, Keebler D, Bórquez A, McRobie E, et al. Using modelling to inform international guidelines for antiretroviral treatment. AIDS. 2014 Jan;28 Suppl 1:S1-4. doi: http://dx.doi.org/10.1097/QAD.0000000000000115 PMID: 24468942
7. A GRADE working group approach for rating the quality of treatment effect estimates from network meta-analysis. BMJ. 2015 06 17;350 jun17 15:h3326. doi: http://dx.doi.org/10.1136/bmj.h3326 PMID: 26085374
8. The guidelines manual. London: National Institute for Health and Clinical Excellence; 2012. Available from: https://www.nice.org.uk/process/pmg6/ chapter/6-reviewing-the-evidence [cited 2016 Jul 19].
9. Stregenga H, Rogers G, Kandaswamy P, Jones D. Network meta-analyses in national clinical guidelines: a description and quality assessment. Berlin: Guidelines International Network; 2012.
10. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Rockville: AIDSinfo; 2016. Available from: https://aidsinfo.nih.gov/guidelines/html/1/adult-and-adolescent-treatment-guidelines/0 [cited 2016 Mar 10].
11. Guidelines version 8 0. Brussels: European AIDS Clinical Society; 2015. Available from: http://www.eacsociety.org/files/2015_eacsguidelines_8_0-english_rev-20160124.pdf [cited 2016 Mar 10].
12. Recommendations for testing, managing, and treating hepatitis C. Alexandria and Arlington: American Association for the Study of Liver Diseases and the Infectious Diseases Society of America; 2016. Available from: http://hcvguidelines.org/sites/default/files/HCV-Guidance:February_2016_a1.pdf [cited 2016 Mar 10].
13. Golder S, Loke YK, Bland M. Meta-analyses of adverse effects data derived from randomised controlled trials as compared to observational studies: methodological overview. PLoS Med. 2011 May;8(5):e1001026. doi: http://dx.doi.org/10.1371/journal.pmed.1001026 PMID: 21559325
14. Schmitz S, Adams R, Walsh C. Incorporating data from various trial designs into a mixed treatment comparison model. Stat Med. 2013 Jul 30;32(17):2935-49. doi: http://dx.doi.org/10.1002/sim.5764 PMID: 23440610